319 related articles for article (PubMed ID: 23774794)
1. Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.
Wang Y; Xu Z; Guo S; Zhang L; Sharma A; Robertson GP; Huang L
Mol Ther; 2013 Oct; 21(10):1919-29. PubMed ID: 23774794
[TBL] [Abstract][Full Text] [Related]
2. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
Yang Y; Li J; Liu F; Huang L
Mol Ther; 2012 Mar; 20(3):609-15. PubMed ID: 22186791
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer.
Kanehira Y; Togami K; Ishizawa K; Sato S; Tada H; Chono S
Pharm Dev Technol; 2019 Nov; 24(9):1095-1103. PubMed ID: 31204552
[TBL] [Abstract][Full Text] [Related]
5. A Glutamine-Rich Carrier Efficiently Delivers Anti-CD47 siRNA Driven by a "Glutamine Trap" To Inhibit Lung Cancer Cell Growth.
Wu J; Li Z; Yang Z; Guo L; Zhang Y; Deng H; Wang C; Feng M
Mol Pharm; 2018 Aug; 15(8):3032-3045. PubMed ID: 29939755
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
[TBL] [Abstract][Full Text] [Related]
7. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.
Chono S; Li SD; Conwell CC; Huang L
J Control Release; 2008 Oct; 131(1):64-9. PubMed ID: 18674578
[TBL] [Abstract][Full Text] [Related]
8. Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy.
Shang T; Yu X; Gu Y; Du R; Cai Y; Li Y; Zheng G; Wang C; Zhang J; Liu J; Han S; Yang B
Int J Biol Macromol; 2023 Nov; 251():126539. PubMed ID: 37634787
[TBL] [Abstract][Full Text] [Related]
9. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
[TBL] [Abstract][Full Text] [Related]
10. Novel nanocarriers for silencing anti-phagocytosis CD47 marker in acute myeloid leukemia cells.
Hassan EM; Zou S
Colloids Surf B Biointerfaces; 2022 Sep; 217():112609. PubMed ID: 35667200
[TBL] [Abstract][Full Text] [Related]
11. Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model.
Abdel-Bar HM; Walters AA; Wang JT; Al-Jamal KT
Adv Healthc Mater; 2021 Apr; 10(7):e2001853. PubMed ID: 33661553
[TBL] [Abstract][Full Text] [Related]
12. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism and benefit of siRNA-mediated targeting of CD47 in cancer.
Zhao X; Matlung H; Kuijpers TW; van den Berg TK
Mol Ther; 2013 Oct; 21(10):1811. PubMed ID: 24081120
[No Abstract] [Full Text] [Related]
14. Reply to "On the mechanism and benefit of siRNA-mediated targeting of CD47 in cancer".
Wang Y; Xu Z; Huang L
Mol Ther; 2013 Oct; 21(10):1812-3. PubMed ID: 24081121
[No Abstract] [Full Text] [Related]
15. [Folic acid modified polyrotaxanes effectively transfer si RNA-CD47 to inhibit the proliferation of melanoma].
Zhu LN; Li YS; Zhou Y; Wang H; Chen JH
Yao Xue Xue Bao; 2016 Mar; 51(3):455-61. PubMed ID: 29859029
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
17. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
[TBL] [Abstract][Full Text] [Related]
18. CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer.
Zhao H; Wang J; Kong X; Li E; Liu Y; Du X; Kang Z; Tang Y; Kuang Y; Yang Z; Zhou Y; Wang Q
Sci Rep; 2016 Jul; 6():29719. PubMed ID: 27411490
[TBL] [Abstract][Full Text] [Related]
19. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Willingham SB; Volkmer JP; Gentles AJ; Sahoo D; Dalerba P; Mitra SS; Wang J; Contreras-Trujillo H; Martin R; Cohen JD; Lovelace P; Scheeren FA; Chao MP; Weiskopf K; Tang C; Volkmer AK; Naik TJ; Storm TA; Mosley AR; Edris B; Schmid SM; Sun CK; Chua MS; Murillo O; Rajendran P; Cha AC; Chin RK; Kim D; Adorno M; Raveh T; Tseng D; Jaiswal S; Enger PØ; Steinberg GK; Li G; So SK; Majeti R; Harsh GR; van de Rijn M; Teng NN; Sunwoo JB; Alizadeh AA; Clarke MF; Weissman IL
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6662-7. PubMed ID: 22451913
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment.
Xu Z; Wang Y; Zhang L; Huang L
ACS Nano; 2014 Apr; 8(4):3636-45. PubMed ID: 24580381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]